Table 2 Patient demographics and baseline clinical data
Variable | All patients n = 21 (%) | Hypothermia n = 9 (%) | Normothermia n = 12 (%) | P-value |
|---|---|---|---|---|
Demographics | ||||
Age (years) | 52.5 ± 11.0 | 45.9 ± 12.2 | 57.4 ± 7.0 | 0.013 |
Gender (male) | 17 (81.0) | 8 (88.9) | 9 (75.0) | 0.422 |
BSA (m2) | 1.72 ± 0.18 | 1.71 ± 0.16 | 1.72 ± 0.20 | 0.930 |
Comorbidities | ||||
Hypertension | 11 (52.4) | 4 (44.4) | 7 (58.3) | 0.528 |
Hyperlipidaemia | 10 (47.6) | 6 (50.0) | 4 (44.4) | 0.801 |
Diabetes mellitus | 9 (42.9) | 5 (41.7) | 4 (44.4) | 0.899 |
Renal failure (CrCl <60 ml/min) | 12 (57.1) | 5 (55.6) | 7 (58.3) | 0.899 |
Coronary artery disease | 17 (81.0) | 6 (66.7) | 11 (91.7) | 0.149 |
Peripheral vascular disease | 3 (14.3) | 1 (11.1) | 2 (16.7) | 0.719 |
Previous stroke | 1 (4.8) | 0 (0) | 1 (8.3) | 0.375 |
Atrial fibrillation | 1 (4.8) | 0 (0) | 1 (8.3) | 0.375 |
Smoking | 12 (57.1) | 6 (66.7) | 6 (50.0) | 0.445 |
LVEF (%) | 23.4 ± 15.8 | 13.9 ± 3.6 | 30.3 ± 17.8 | 0.013 |